J&J gets FDA approval for smaller Cypher stent

09/21/2009 | NYTimes.com

Johnson & Johnson received FDA approval for a 2.25-millimeter version of its Cypher drug-eluting stent, designed to treat smaller blood vessels. The agency granted approval after a study showed that the device was more effective than bare-metal stents in keeping small blood vessels from reclogging.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD